Spago Nanomedical
BioStock: Positive data in Spago's phase IIa endometriosis trial
Read the interview with Mats Hansen at biostock.se:
Positive data in Spago’s phase IIa endometriosis trial - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
Datum | 2023-12-20, kl 08:46 |
Källa | Cision |
![](https://static.allaaktier.se/ads/etoro-logo.png)
Copy Trading innebär inte investeringsråd. Värdet på dina investeringar kan gå upp eller ned. Ditt kapital löper risk.